Keywords: thrombogenics, transfers, technology, bharat, nv, belgian, biotechnology

ThromboGenics transfers technology to Bharat

Article | 10 September 2007

Print This

ThromboGenics NV, a Belgian biotechnology firm focused on vascular disease, says it has completed the technology transfer to Bharat Biotech ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in